Eli Lilly's growth is fueled by high demand for its key drugs, Mounjaro (for type 2 diabetes ... of 25.7% from the current levels. With headquarters in the heart of Chicago's financial district ...

FILE - A sign for Eli Lilly & Co. stands outside their corporate headquarters in Indianapolis on April 26 ... said that a nationwide shortage of Eli Lilly’s Zepbound and Mounjaro has been resolved, ...

FILE - A sign for Eli Lilly & Co. stands outside their corporate headquarters in Indianapolis ... shortage of Eli Lilly’s Zepbound and Mounjaro has been resolved, eliminating the need for ...

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

FILE - A sign for Eli Lilly & Co. stands outside their corporate headquarters in Indianapolis ... Zepbound is FDA-approved to treat obesity and Mounjaro is approved for diabetes.

The Food and Drug Administration said that a nationwide shortage of Eli Lilly’s Zepbound and Mounjaro has been ... which is also home to BXP’s headquarters and the three-story observatory ...

Lilly also announced other multibillion-dollar manufacturing expansion projects near its Indianapolis headquarters earlier this year. Eli Lilly and Co. said Thursday that it has slated more than $ ...

HONG KONG (AP) — Asian stocks were mixed Wednesday followed Wall Street’s mostly positive performance ahead of key U.S.